Skip to main content
Biocartis Group NV logo

Biocartis Group NV — Investor Relations & Filings

Ticker · BCART ISIN · BE0974281132 LEI · 549300J4HOJL5KG8HY54 BR Manufacturing
Filings indexed 636 across all filing types
Latest filing 2020-01-27 Board/Management Inform…
Country BE Belgium
Listing BR BCART

About Biocartis Group NV

https://www.biocartis.com/en

Biocartis Group NV is a molecular diagnostics company that develops and commercializes its proprietary Idylla™ platform. This fully automated, sample-to-result system is designed to provide fast, easy, and actionable molecular diagnostic results, making advanced testing accessible to laboratories of any size. The company's primary focus is in the field of oncology, offering a menu of tests that support the diagnosis and treatment of various cancers, including lung, colorectal, melanoma, and breast cancer. Biocartis aims to enable personalized medicine for patients by providing universal access to molecular testing. The company also collaborates with pharmaceutical partners in the development of companion diagnostics.

Recent filings

Filing Released Lang Actions
Biocartis kondigt vertrek CFO aan
Board/Management Information Classification · 99% confidence The document is titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Regulated Information Press Release) and its main subject is the announcement of the departure of the Chief Financial Officer (CFO), Ewoud Welten. This type of announcement, concerning a change in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). The document is a formal announcement, not a full financial report (like 10-K or IR) or a transcript (CT).
2020-01-27 Dutch
TransparencyNotification_Sycomore_Below3_Dec2019.pdf
Major Shareholding Notification Classification · 98% confidence The document is a formal notification written in French concerning changes in share ownership ('Acquisition ou cession de titres conférant le droit de vote' and 'Franchissement vers le bas du seuil minimum'). It details the notification date (06/12/2019), the notifying entity (SYCOMORE ASSET MANAGEMENT SA), the issuer (BIOCARTIS), and the resulting voting rights percentage (2.99%). This structure and content strongly align with regulatory filings related to insider transactions or major shareholding changes. Given the options, 'Major Shareholding Notification' (MRQ) is the most appropriate classification for a document detailing the crossing of a significant ownership threshold, even though it is a foreign regulatory filing format (likely AMF in France). It is not an earnings release, annual report, or management discussion.
2019-12-12 French
191209_PR_TranspNotif_SycomoreBelow3Threshold_ENG_FINAL.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is explicitly titled "PRESS RELEASE REGULATED INFORMATION" and details the receipt of a "transparency notification" regarding a decrease in shareholding below the 3% threshold, citing the Belgian Transparency Act. This type of disclosure, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is presented as a press release, the core content is the notification of a change in major shareholding.
2019-12-12 English
191209_PR_TranspNotif_SycomoreBelow3Threshold_NL_FINAL.pdf
Director's Dealing Classification · 98% confidence The document is titled "PERSBERICHT GEREGLEMENTEERDE INFORMATIE" (Regulated Information Press Release) and announces the receipt of a 'transparantiekennisgeving' (transparency notification) regarding a change in significant shareholding (Sycomore Asset Management SA falling below the 3% threshold). This type of mandatory disclosure concerning changes in major shareholdings is specifically covered by the 'Major Shareholding Notification' category (MRQ) under Belgian regulations mentioned in the text. Although it is a press release, the core content is the notification of a change in ownership threshold, making MRQ the most precise fit over the general RPA or RNS.
2019-12-12 Dutch
Transparency Notification Johnson.pdf
Major Shareholding Notification Classification · 99% confidence The document is clearly identified as 'Form TR-1 BE' from the 'FINANCIAL SERVICES AND MARKETS AUTHORITY' (FSMA). This form is a 'Transparency notification' regarding the 'Acquisition or disposal of voting securities or voting rights' by a major shareholder (Johnson & Johnson). This type of filing reports changes in significant shareholdings, crossing ownership thresholds. This directly corresponds to the definition of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels (crossing thresholds).
2019-11-27 English
191127_PR_TranspNotif_JohnsonBelow10Threshold_ENG_FINAL.pdf
Regulatory Filings Classification · 98% confidence The document is explicitly titled "PRESS RELEASE REGULATED INFORMATION" and details the disclosure of a transparency notification regarding a change in major shareholdings (Johnson & Johnson Innovation – JJDC, Inc. falling below the 10% threshold) as required by the Belgian Transparency Act. This type of filing, which reports changes in significant ownership stakes, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is presented as a press release, the core content is the notification of a change in major shareholding, making MRQ the most specific classification over the general Regulatory Filing (RNS).
2019-11-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.